{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T04:20:58Z","timestamp":1648959658243},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1001\/jamapsychiatry.2018.0927","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T01:41:14Z","timestamp":1534815674000},"page":"1088","source":"Crossref","is-referenced-by-count":1,"title":["A Case of Severe Intractable Contamination-Based Obsessive-Compulsive Disorder"],"prefix":"10.1001","volume":"75","author":[{"given":"Brian P.","family":"Brennan","sequence":"first","affiliation":[{"name":"Obsessive-Compulsive Disorder Institute, McLean Hospital, Belmont, Massachusetts"},{"name":"Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts"},{"name":"Department of Psychiatry, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan J.","family":"Jacoby","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Harvard Medical School, Boston, Massachusetts"},{"name":"Obsessive-Compulsive and Related Disorders Program, Massachusetts General Hospital, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alik S.","family":"Widge","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Neurotherapeutics, Massachusetts General Hospital, Boston"},{"name":"Picower Institute for Learning and Memory, Massachusetts Institute for Technology, Cambridge"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"8","key":"ycg180002r1","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cpr.2004.08.004","article-title":"A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder.","volume":"24","author":"Eddy","year":"2004","journal-title":"Clin Psychol Rev"},{"key":"ycg180002r2","article-title":"Neuroscientifically informed formulation and treatment planning for patients with obsessive-compulsive disorder: a review","author":"Dougherty","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"ycg180002r3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1176\/appi.ajp.162.1.151","article-title":"Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.","volume":"162","author":"Foa","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"11","key":"ycg180002r4","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamapsychiatry.2013.1932","article-title":"Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.","volume":"70","author":"Simpson","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"ycg180002r6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.janxdis.2016.03.006","article-title":"Dropout rates in exposure with response prevention for obsessive-compulsive disorder: what do the data really say?","volume":"40","author":"Ong","year":"2016","journal-title":"J Anxiety Disord"},{"issue":"3","key":"ycg180002r7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","article-title":"Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.","volume":"132","author":"Pittenger","year":"2011","journal-title":"Pharmacol Ther"},{"issue":"4","key":"ycg180002r8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/YCT.0000000000000335","article-title":"Transcranial magnetic stimulation for obsessive-compulsive disorder: an updated systematic review and meta-analysis.","volume":"32","author":"Trevizol","year":"2016","journal-title":"J ECT"},{"issue":"1","key":"ycg180002r10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/mp.2008.55","article-title":"Deep brain stimulation of the ventral internal capsule\/ventral striatum for obsessive-compulsive disorder: worldwide experience.","volume":"15","author":"Greenberg","year":"2010","journal-title":"Mol Psychiatry"},{"key":"ycg180002r9","volume-title":"Obsessive-Compulsive Disorder: Phenomenology, Pathophysiology, and Treatment","author":"Keen","year":"2017"},{"key":"ycg180002r5","unstructured":"National Institute of Health and Clinical Excellence. Obsessive-compulsive disorder and body dysmorphic disorder: treatment. NICE guideline (CG31). https:\/\/www.nice.org.uk\/guidance\/CG31. Accessed July 5, 2018."}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2696593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T18:12:53Z","timestamp":1538590373000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpsyc.jamanetwork.com\/article.aspx?doi=10.1001\/jamapsychiatry.2018.0927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.0927","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}